← Back to Cognitive Deep Dive

Dihexa

Angiotensin IV analogue — potent cognitive enhancer

Protocol Summary

Route
Oral / SubQ
Dose Range
5–20 mg oral, 1–5 mg subq
Cycling
Emerging — no established protocol
Evidence Tier
animal

Primary Benefits

Safety Profile

CAUTION: Pro-cancer concern via HGF/c-Met pathway. No human safety data. Research chemical only.

Research Findings

No findings yet. The weekly research pipeline will populate this section.